OPPORTUNITIES AND FUTURE PERSPECTIVES FOR REMOTE MONITORING OF PATIENTS WITH IMPLANTED DEVICES
https://doi.org/10.17802/2306-1278-2019-8-2-98-106
Abstract
Today implantable cardiac devices (ICD) are advanced therapeutic and preventive tools ensuring the collection and transmission of statistical and diagnostic patient data. The information obtained from implanted devices allows analyzing patients’ condition, selecting optimal treatment strategy, predicting and preventing possible complications. The number of ICD recipients is rapidly growing. Over 1,000 devices per 1 million population are implanted in Europe and the US annually. In the Russian Federation this number reaches 300 devices per 1 million population. Routine medical checkups of patients with ICD should be performed 2–4 times a year, with an average length of about 20 minutes. It means that only in the Russian Federation physicians will have to work 20–40 thousand extra hours with a tendency towards its increase as this figure will grow simultaneously with growing patients’ number. Remote monitoring (RM) technologies may solve this problem. In 2000 Biotronik AG developed the world's first system for remote monitoring of anti-arrhythmic devices called the “Home Monitoring” system. It is based on the mobile RM of patients who received ICD. The information collected by the devices is transmitted to a special service center via mobile communication networks and after processing, the information is transferred to a physician’s website along with a text message and a fax. The information is instantly delivered from a patient to a physician. A closed information network "patient-service center-physician" was developed for the hospitals and their patients, providing a novel advanced monitoring and timely treatment of the patient.
About the Authors
N. N. Lomidze
A.V. Vishnevsky Institute of Surgery
Russian Federation
Russian Federation
27, Bolshaya Serpuhovskaya St., Moscow, 117997
V. A. Vaskovskiy
A.V. Vishnevsky Institute of Surgery
Russian Federation
Russian Federation
M. V. Yashkov
A.V. Vishnevsky Institute of Surgery
Russian Federation
Russian Federation
E. A. Artukhina
A.V. Vishnevsky Institute of Surgery
Russian Federation
Russian Federation
A. Sh. Revishvili
A.V. Vishnevsky Institute of Surgery
Russian Federation
Russian Federation
References
1. Bokeria L.A., Neminushchiy N.M., Postol A.S. Cardiac resynchronization therapy. Indications and novel approaches to the improvement of its efficiency. Complex Issues of Cardiovascular Diseases. 2018;7(3):102-116. doi: https://doi.org/10.17802/23061278-2018-7-3-102-116 (In Russian)
2. Lomidze N.N., Revishvili A.Sh., Kuptsov V.V., Spiridonov A.A. Remote monitoring of patients: results of clinical trials. Vestnik aritmologii. 2013; 74: 71-76. (In Russian)
3. Revishvili A.SH., Ardashev A.V., Bojcov S.A., Bokeriya O.L., Goluhova Е.Z., Davtyan K.V., Zenin S.A., Kuznecov V.A., Kupcov V.V., Lebedev D.S., Lomidze N.N., Medvedev M.M., Nedostup A.V., Neminushchij M.N., Pevzner A.V., Pokushalov Е.A.,Rzaev F.G., Syrkin A.L., Termosesov S.A. Klinicheskie rekomendacii po provedeniyu elektrofiziologicheskih issledovanij, kateternoj ablacii i primeneniyu implantiruemyh antiaritmicheskih ustrojstv. 3-e izd. Moskva: VNOA; 2013. (In Russian)
4. Revishvili A.Sh., Lomidze N.N., Sungatov R.Sh.1, Khasanov I.Sh. Remote diagnosis and integration of the medical data for improvement of effectiveness of electrocardiotherapy. Vestnik aritmologii. 2016. № 85. С. 5-18. (In Russian)
5. Lomidze N.N., Revishvili A.SH., Magomedova S.M. Udalennyj monitoring pacientov s implantirovannymi antiaritmicheskimi ustrojstvami-rezul'taty vos'miletnego nablyudeniya. Byulleten' NCSSKH im. A.N. Bakuleva RAMN Serdechno-sosudistye zabolevaniya. 2014; 15 (S6): 93. (In Russian)
6. Ellery S., Pakrashi T., Paul V., Sack S. Predicting mortality and rehospitalization in heart failure patients with home monitoring--the Home CARE pilot study. Clin Res Cardiol 2006; 95 (Suppl .3): III29–35. DOI: 10.1007/s00392-006-1306-6
7. Fauchier L., Sadoul N., Kouakam C., Briand F., Chauvin M., Babuty D., Clementy J. Potential cost savings by telemedicine-assisted long-term care of implantable cardioverter defibrillator recipients. Pacing Clin Electrophysiol. 2005; 28 (Suppl .1): S255–9. DOI: 10.1111/j.1540-8159.2005.00071.x
8. Guédon-Moreau L., Chevalier .P, Marquié C., Kouakam C., Klug D., Lacroix D., Brigadeau F., Kacet S; ECOST trial Investigators. Contributions of remote monitoring to the follow-up of implantable cardioverter-defibrillator leads under advisory. Eur Heart J 2010; 31 (18): 2246–52. doi: 10.1093/eurheartj/ehq203.
9. Halimi F et al: Optimized post-operative surveillance of permanent pacemakers by home monitoring: the OEDIPE trial. Europace 2008; 10 (12): 1392–9. doi: 10.1093/europace/eun250.
10. Hauck M., Bauer A., Voss F., Weretka S., Katus H.A., Becker R. "Home monitoring" for early detection of implantable cardioverterdefibrillator failure: a single-center prospective observational study. Clin Res Cardiol 2009; 98: 19–24. doi: 10.1007/s00392-008-0712-3.
11. Heidbüchel H., Clémenty J., Attuel P., Dessenne X., Amara W.; OEDIPE trial Investigators. Potential role of remote monitoring for scheduled and unscheduled evaluations of patients with an implantable defibrillator. Europace 2008; 10 (3): 351–7 June 2008.
12. Klersy C., De Silvestri A., Gabutti G., Regoli F., Auricchio A. A meta-analysis of remote monitoring of heart failure patients. J Am Coll Cardiol 2009; 54 (18): 1683–94. doi: 10.1016/j.jacc.2009.08.017.
13. Lazarus A. Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems: analysis of a worldwide database. Pacing Clin Electrophysiol 2007; 30 (Suppl .1): S2–12
14. Mabo P. Home monitoring for pacemaker follow-up: The first prospective randomised trial. Presentation at Cardiostim; 2010 Jun 16–19, Nice Acropolis, French Riviera, 2010
15. Assessment report. Remote monitoring systems for patients with implanted cardiac devices. Medical Services Advisory Committee (MSAC) Available from: http://www.msac.gov.au/ internet/msac/publishing.nsf/Content/497D392D6F456CB1CA25 801000123B48/$File/1111-Assessment-Report.pdf
16. Ricci R.P., Morichelli L., Gargaro A., Laudadio M.T., Santini M. Home monitoring in patients with implantable cardiac devices: is there a potential reduction of stroke risk? Results from a computer model tested through monte carlo simulations. J Cardiovasc Electrophysiol 2009; 20 (11): 1244–51. doi: 10.1111/j.1540-8167.2009.01543.x
17. Ricci R.P., Morichelli L., Santini M. Home monitoring remote control of pacemaker and implantable cardioverter defibrillator patients in clinical practice: impact on medical management and health-care resource utilization. Europace 2008; 10 (2): 164–70. doi: 10.1093/europace/eum289.
18. Ricci R.P., Morichelli L., Quarta L., Sassi A., Porfili A., Laudadio M.T., Gargaro A., Santini M. Long-term patient acceptance of and satisfaction with implanted device remote monitoring. Europace 2010; 12 (5): 674–9. doi: 10.1093/europace/euq046.
19. Spencker S., Coban N., Koch L., Schirdewan A., Müller D. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure. Europace 2009; 11: 483–88. doi: 10.1093/europace/eun350
20. Varma N., Michalski J., Epstein A.E., Schweikert R. Automatic remote monitoring of implantable cardioverter-defibrillator lead and generator performance: the Lumos-T Safely RedUceS RouTine Office Device Follow-Up (TRUST) trial. Circ Arrhythm Electrophysiol 2010; 3 (5): 428–3 doi: 10.1161/CIRCEP.110.9519626.
21. Varma N., Epstein A.E., Irimpen A., Schweikert R., Love C.; TRUST Investigators.Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation 2010; 122 (4): 325–32. doi: 10.1161/CIRCULATIONAHA.110.937409.
22. Wilkoff B.L., Auricchio A., Brugada J., Cowie M., Ellenbogen K.A., Gillis A.M., Hayes D.L. et al. HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations. Heart Rhythm 2008; 5 (6): 907–25. doi: 10.1093/europace/eun122.
23. Zartner P., Handke R., Photiadis J., Brecher A.M., Schneider M.B. Performance of an autonomous telemonitoring system in children and young adults with congenital heart diseases. Pacing Clin Electrophysiol 2008; 31 (10): 1291–9. doi: 10.1111/j.1540-8159.2008.01180.x.
Review
For citations:
Lomidze N.N., Vaskovskiy V.A., Yashkov M.V., Artukhina E.A., Revishvili A.Sh. OPPORTUNITIES AND FUTURE PERSPECTIVES FOR REMOTE MONITORING OF PATIENTS WITH IMPLANTED DEVICES. Complex Issues of Cardiovascular Diseases. 2019;8(2):98-106. (In Russ.) https://doi.org/10.17802/2306-1278-2019-8-2-98-106
Views:
941
